Matching Pairs Diabetes Oral MedsOnline version NUr115 Oral Diabetic Agents by Concetta Fiorentino 1 Inhibit production of glucose by the liver. 2 Stimulate pancreas to secrete insulin. 3 Stimulate beta cells of the pancreas. 4 Sensitize body tissue to insulin: stimulates insulin receptor sites. 5 Do not increased insulin secretion. 6 Usually given once a day. 7 Possible side-effect of impaired platelet function. 8 Enhances glucose-dependent insulin secretion. 9 Prevents kidneys from reabsorbing glucose. 10 Increase and prolong the action of the hormone that increases insulin release and decreases glucagon levels. 11 Drug to drug interaction with NSAIDS. glipizide Sodium-glucose co-transporter 2 inhibitors (empagliflozin/Jardiance Biguanides (metformin (Glucophage) Metformin with glyburide (Glucovance) Avandia Non-sulfonylurea insulin secretagogues (repaglinide/Prandin, nateglinide/Starlix) Second generation sulfonylureas (glipizide (Glucotrol) Glyburide (DiaBeta) Glimepiride (Amaryl) Glucagon-like peptide-1 agonist (liraglutide/Victoza,, dulaglutide/Trulicity) Thiazolidinediones (pioglitazone (actos, rosiglitazone/Avandia) Alpha-glucosidase inhibitors (acarbose/Precose, miglitol (Glyset) Dipeptidyl Pepidase-4 Inhibitors (sitagliptin/Januvia, vildagliptin /Galvus) Januvia